Research Headlines - Replacing an enzyme to control a very rare disease
[Source: Research & Innovation]
Until recently, there was no treatment specific to alpha-mannosidosis, one of the many rare diseases that jointly affect some 30 million citizens in Europe alone. Today, there is as EU-funded research developed enzyme-replacement therapy to stop the illness in its tracks, and this medicine is on the market.
from EUROPA - Syndicated Research News Feed https://ift.tt/3dvzOsF
via IFTTT
from EUROPA - Syndicated Research News Feed https://ift.tt/3dvzOsF
via IFTTT
Comments
Post a Comment